139 related articles for article (PubMed ID: 32403147)
1. GHRH Antagonists Protect Against Hydrogen Peroxide-Induced Breakdown of Brain Microvascular Endothelium Integrity.
Barabutis N; Akhter MS; Uddin MA; Kubra KT; Schally AV
Horm Metab Res; 2020 May; 52(5):336-339. PubMed ID: 32403147
[TBL] [Abstract][Full Text] [Related]
2. A glimpse at growth hormone-releasing hormone cosmos.
Barabutis N
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1632-1634. PubMed ID: 32289177
[TBL] [Abstract][Full Text] [Related]
3. Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells.
Siejka A; Schally AV; Block NL; Barabutis N
Prostate; 2010 Jul; 70(10):1087-93. PubMed ID: 20232355
[TBL] [Abstract][Full Text] [Related]
4. Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.
Klukovits A; Schally AV; Szalontay L; Vidaurre I; Papadia A; Zarandi M; Varga JL; Block NL; Halmos G
Cancer; 2012 Feb; 118(3):670-80. PubMed ID: 21751186
[TBL] [Abstract][Full Text] [Related]
5. Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice.
Recinella L; Chiavaroli A; Orlando G; Ferrante C; Marconi GD; Gesmundo I; Granata R; Cai R; Sha W; Schally AV; Brunetti L; Leone S
Sci Rep; 2020 Jan; 10(1):732. PubMed ID: 31959947
[TBL] [Abstract][Full Text] [Related]
6. The effect of GHRH antagonists on human glioblastomas and their mechanism of action.
Pozsgai E; Schally AV; Zarandi M; Varga JL; Vidaurre I; Bellyei S
Int J Cancer; 2010 Nov; 127(10):2313-22. PubMed ID: 20162575
[TBL] [Abstract][Full Text] [Related]
7. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.
Szalontay L; Schally AV; Popovics P; Vidaurre I; Krishan A; Zarandi M; Cai RZ; Klukovits A; Block NL; Rick FG
Cell Cycle; 2014; 13(17):2790-7. PubMed ID: 25486366
[TBL] [Abstract][Full Text] [Related]
8. Suppression of reactive oxygen species in endothelial cells by an antagonist of growth hormone-releasing hormone.
Akhter MS; Barabutis N
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22879. PubMed ID: 34369038
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCδ-mediated activation of p53/p21.
Wu HM; Schally AV; Cheng JC; Zarandi M; Varga J; Leung PC
Cancer Lett; 2010 Dec; 298(1):16-25. PubMed ID: 20630651
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption.
Akhter MS; Kubra KT; Barabutis N
Endocrine; 2023 Mar; 79(3):587-592. PubMed ID: 36261700
[TBL] [Abstract][Full Text] [Related]
12. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
[TBL] [Abstract][Full Text] [Related]
13. Effect of growth hormone-releasing hormone (GHRH) and GHRH antagonist (MZ-4-71) on interferon-gamma secretion from human peripheral blood mononuclear cells in vitro.
Siejka A; Ławnicka H; Komorowski J; Stepień T; Krupiński R; Stepień H
Neuropeptides; 2004 Feb; 38(1):35-9. PubMed ID: 15003714
[TBL] [Abstract][Full Text] [Related]
14. The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines.
Pozsgai E; Schally AV; Hocsak E; Zarandi M; Rick F; Bellyei S
Int J Oncol; 2011 Oct; 39(4):1025-32. PubMed ID: 21701777
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro.
Csernus V; Schally AV; Groot K
Peptides; 1999; 20(7):843-50. PubMed ID: 10477085
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.
Barabutis N; Schally AV
Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20470-5. PubMed ID: 19075233
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-acting antagonists of growth hormone (GH)-releasing hormone on GH and cyclic adenosine 3',5'-monophosphate release in superfused rat pituitary cells.
Horváth JE; Zarándi M; Groot K; Schally AV
Endocrinology; 1995 Sep; 136(9):3849-55. PubMed ID: 7649091
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression.
Wu HM; Huang HY; Schally AV; Chao A; Chou HH; Leung PC; Wang HS
Oncotarget; 2017 Jan; 8(3):4410-4421. PubMed ID: 28032599
[TBL] [Abstract][Full Text] [Related]
19. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.
Muñoz-Moreno L; Arenas MI; Schally AV; Fernández-Martínez AB; Zarka E; González-Santander M; Carmena MJ; Vacas E; Prieto JC; Bajo AM
Int J Cancer; 2013 Feb; 132(4):755-65. PubMed ID: 22777643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
